A recent study in Nature Neuroscience provides new insights into how amyloid-beta and tau proteins, which accumulate in the ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years ...

Complex problems often require creative solutions, and the increasing global burden of Alzheimer’s disease certainly ...

A curious link between Alzheimer's and insulin resistance is now so well-established, the neurodegenerative disease is ...

Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques rather than neuronal damage.

An analysis of cerebrospinal fluid has uncovered several proteins likely involved in the development and progression of ...

A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led ...

Alzheimer’s affects over 50 million people globally, but non-human primates rarely exhibit the toxic protein deposits central ...

For three years, he underwent monthly infusions when, in July 2023, he no longer met the criteria to be diagnosed with ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...

Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...